Reference
Miller JA, et al. Cost-Effectiveness of Nasopharyngeal Carcinoma Screening with Epstein-Barr Virus Polymerase Chain Reaction or Serology in High-Incidence Populations Worldwide. Journal of the National Cancer Institute : 22 Dec 2020. Available from: URL: http://doi.org/10.1093/jnci/djaa198
Rights and permissions
About this article
Cite this article
EBV-based nasopharyngeal carcinoma screening cost effective in many populations worldwide. PharmacoEcon Outcomes News 869, 12 (2021). https://doi.org/10.1007/s40274-021-7379-7
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40274-021-7379-7